Stockscreener 앱 받기
3.15
2.17%
-0.07
시간 외 거래:
3.10
-0.05
-1.59%
전일 마감가:
$3.22
열려 있는:
$3.43
하루 거래량:
2.54M
Relative Volume:
4.03
시가총액:
$316.89M
수익:
-
순이익/손실:
$-60.14M
주가수익비율:
-4.4397
EPS:
-0.7095
순현금흐름:
$-68.17M
1주 성능:
+12.50%
1개월 성능:
-3.96%
6개월 성능:
+52.17%
1년 성능:
+5.35%
1일 변동 폭
$3.12
$3.80
1주일 범위
$2.54
$3.80
52주 변동 폭
$1.4299
$4.00
Ac Immune Sa Stock (ACIU) Company Profile
ACIU을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ACIU
Ac Immune Sa
|
3.15 | 323.93M | 0 | -60.14M | -68.17M | -0.7095 |
|
VRTX
Vertex Pharmaceuticals Inc
|
452.04 | 113.14B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
741.29 | 78.49B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
877.94 | 54.76B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
397.55 | 54.51B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
INSM
Insmed Inc
|
197.01 | 41.64B | 447.02M | -1.18B | -906.14M | -6.1812 |
Ac Immune Sa Stock (ACIU) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-05-31 | 개시 | BTIG Research | Buy |
| 2019-02-01 | 다운그레이드 | UBS | Buy → Neutral |
| 2019-01-04 | 개시 | UBS | Buy |
| 2018-04-05 | 개시 | H.C. Wainwright | Buy |
| 2018-03-23 | 다운그레이드 | Credit Suisse | Outperform → Neutral |
| 2016-10-18 | 개시 | Credit Suisse | Outperform |
| 2016-10-18 | 개시 | Jefferies | Buy |
| 2016-10-18 | 개시 | Leerink Partners | Outperform |
모두보기
Ac Immune Sa 주식(ACIU)의 최신 뉴스
AC Immune SA (ACIU) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Aug Macro: Will AC Immune SA IMR stock outperform value peers2025 Technical Overview & Precise Swing Trade Alerts - moha.gov.vn
AC Immune Perks Up On Positive Parkinson’s Data - Citeline News & Insights
AC Immune’s Parkinson’s vaccine advances on promising biomarker profile - BioCentury
AC Immune Simulates Curiosity in Neurodegenerative Fight with Global Conference Plans - StocksToTrade
AC Immune (ACIU) Stock: Surges as ACI-7104.056 Shows Potential in Early Parkinson’s Disease - parameter.io
AC Immune Trial Shows Early Signs Immunotherapy May Slow Parkinson's - Benzinga
Promising Advancements in Parkinson’s Treatment: AC Immune’s ACI-7104 Vaccine Shows Groundbreaking Results - TipRanks
AC Immune SA: Navigating Market Momentum - timothysykes.com
ACIU Surges 30% on Positive Parkinson's Therapy Trial Results - GuruFocus
AC Immune’s Parkinson’s disease candidate shows positive Phase 2 results - TipRanks
ACIU: ACI-7104.056 shows promise in slowing Parkinson's progression with strong safety and efficacy - TradingView
AC Immune’s Parkinson’s treatment shows promise in slowing disease - Investing.com
AC Immune surges on Parkinson’s drug data (ACIU:NASDAQ) - Seeking Alpha
AC Immune (ACIU) Reports Encouraging Phase 2 Results for Parkins - GuruFocus
Why Is AC Immune Stock Up Over 23% Today? - Stocktwits
Ac Immune shares climb 32.6% premarket after co reports positive trial data for Parkinson's disease therapy - marketscreener.com
AC Immune stock rises after positive Parkinson’s disease trial data By Investing.com - Investing.com India
AC Immune Reports Promising Phase 2 Results for Parkinson’s Therapy - TipRanks
AC Immune Reports Positive Interim Phase 2 Data for ACI-7104.056 Indicating Potential to Slow Parkinson's Disease Progression - Quiver Quantitative
AC Immune Positive Interim Phase 2 Data on ACI-7104.056 Support Potential Slowing of Progression of Parkinson’s Disease - GlobeNewswire Inc.
AC Immune SA's (NASDAQ:ACIU) stock price dropped 11% last week; retail investors would not be happy - simplywall.st
Sentiment Watch: Will AC Immune SA stock deliver long term returns - moha.gov.vn
Aug Reactions: Why ETFs are accumulating AC Immune SA IMR stockEarnings Risk Summary & Daily Stock Trend Watchlist - BỘ NỘI VỤ
Quarterly Risk: Why analysts upgrade AC Immune SA stock2025 Sector Review & Fast Momentum Stock Entry Tips - BỘ NỘI VỤ
How AC Immune SA (IMR) stock reacts to weak economyVolume Spike & Weekly High Potential Alerts - Newser
Is AC Immune SA (IMR) stock a top dividend aristocrat candidate2025 Short Interest & Reliable Price Action Trade Plans - Newser
How big funds are accumulating AC Immune SA (IMR) stock2025 Market Sentiment & Free Reliable Trade Execution Plans - Newser
Will AC Immune SA (IMR) stock profit from AI boomCPI Data & Comprehensive Market Scan Insights - Newser
Why AC Immune SA (IMR) stock trades below fair valueQuarterly Market Review & Capital Efficiency Focused Strategies - Newser
How geopolitical risks impact AC Immune SA (IMR) stock2025 Volume Leaders & Fast Entry Momentum Alerts - Newser
Will AC Immune SA (IMR) stock benefit from commodity supercycleWeekly Risk Summary & Real-Time Chart Pattern Alerts - Newser
What analysts say about AC Immune SA IMR stockShort Selling Opportunities & Free Explosive Wealth Accumulation - earlytimes.in
Adversity is less terrifying than hope: AC Immune SA (ACIU) - Setenews
Is AC Immune SA stock a top pick in earnings seasonQuarterly Trade Report & Expert Approved Momentum Ideas - newser.com
Why millennials buy AC Immune SA (IMR) stockJuly 2025 Catalysts & Fast Exit Strategy with Risk Control - newser.com
Will AC Immune SA stock recover faster than peersJuly 2025 Macro Moves & Community Supported Trade Ideas - newser.com
Is AC Immune SA (IMR) stock positioned for digital growth eraJuly 2025 Short Interest & AI Powered Buy/Sell Recommendations - newser.com
Why analysts remain bullish on AC Immune SA stockGDP Growth & Pattern Based Trade Signal System - newser.com
Can AC Immune SA stock resist sector downturnsEarnings Risk Summary & Expert Curated Trade Setup Alerts - newser.com
Signal strength of AC Immune SA stock in tech scannersBuy Signal & Momentum Based Trading Signals - newser.com
Why AC Immune SA stock remains on watchlistsWeekly Trade Recap & Free Community Consensus Stock Picks - newser.com
Ac Immune Sa (ACIU) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.08%
0.91%
자본화:
|
볼륨(24시간):